Global Acetaminophen-Opioid Combination Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI10249894

Publication Date:

October 14, 2024

Pages:

113

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

An acetaminophen-opioid combination is a type of medication that combines acetaminophen (a non-opioid pain reliever) with an opioid analgesic, such as hydrocodone or oxycodone, to treat moderate to severe pain. The acetaminophen enhances the pain-relieving effects of the opioid, allowing for more effective pain control with potentially lower doses of the opioid. This combination is often prescribed for short-term pain management after surgery or injury. However, it carries risks such as addiction, dependence, and liver damage if used improperly or over long periods.
The global Acetaminophen-Opioid Combination market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (publisher)' newest research report, the 鈥淎cetaminophen-Opioid Combination Industry Forecast鈥� looks at past sales and reviews total world Acetaminophen-Opioid Combination sales in 2022, providing a comprehensive analysis by region and market sector of projected Acetaminophen-Opioid Combination sales for 2023 through 2029. With Acetaminophen-Opioid Combination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acetaminophen-Opioid Combination industry.
This Insight Report provides a comprehensive analysis of the global Acetaminophen-Opioid Combination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Acetaminophen-Opioid Combination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Acetaminophen-Opioid Combination market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acetaminophen-Opioid Combination and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acetaminophen-Opioid Combination.
United States market for Acetaminophen-Opioid Combination is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Acetaminophen-Opioid Combination is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Acetaminophen-Opioid Combination is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Acetaminophen-Opioid Combination players cover Abbott, Endo Pharmaceuticals, 骋谤眉苍别苍迟丑补濒, Hamilton Kent., Trio Remedies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Acetaminophen-Opioid Combination market by product type, application, key players and key regions and countries.
Segmentation by Type:
Hydrocodone/Acetaminophen
Oxycodone/Acetaminophen
Codeine/Acetaminophen
Tramadol/Acetaminophen
Others
Segmentation by Application:
Acute Pain
Chronic Pain
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Hydrocodone/Acetaminophen
Oxycodone/Acetaminophen
Codeine/Acetaminophen
Tramadol/Acetaminophen
Others
Segmentation by Application:
Acute Pain
Chronic Pain
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Endo Pharmaceuticals
骋谤眉苍别苍迟丑补濒
Hamilton Kent.
Trio Remedies
Purdue Pharmaceuticals
Teva Pharmaceutical
Laboratoire Riva
Johnson & Johnson
Mallinckrodt Pharmaceuticals
AstraZeneca

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Acetaminophen-Opioid Combination Market Size 2019-2030
2.1.2 Acetaminophen-Opioid Combination Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Acetaminophen-Opioid Combination by Country/Region, 2019, 2023 & 2030
2.2 Acetaminophen-Opioid Combination Segment by Type
2.2.1 Hydrocodone/Acetaminophen
2.2.2 Oxycodone/Acetaminophen
2.2.3 Codeine/Acetaminophen
2.2.4 Tramadol/Acetaminophen
2.2.5 Others
2.3 Acetaminophen-Opioid Combination Market Size by Type
2.3.1 Acetaminophen-Opioid Combination Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Acetaminophen-Opioid Combination Market Size Market Share by Type (2019-2024)
2.4 Acetaminophen-Opioid Combination Segment by Application
2.4.1 Acute Pain
2.4.2 Chronic Pain
2.5 Acetaminophen-Opioid Combination Market Size by Application
2.5.1 Acetaminophen-Opioid Combination Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Acetaminophen-Opioid Combination Market Size Market Share by Application (2019-2024)
3 Acetaminophen-Opioid Combination Market Size by Player
3.1 Acetaminophen-Opioid Combination Market Size Market Share by Player
3.1.1 Global Acetaminophen-Opioid Combination Revenue by Player (2019-2024)
3.1.2 Global Acetaminophen-Opioid Combination Revenue Market Share by Player (2019-2024)
3.2 Global Acetaminophen-Opioid Combination Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Acetaminophen-Opioid Combination by Region
4.1 Acetaminophen-Opioid Combination Market Size by Region (2019-2024)
4.2 Global Acetaminophen-Opioid Combination Annual Revenue by Country/Region (2019-2024)
4.3 Americas Acetaminophen-Opioid Combination Market Size Growth (2019-2024)
4.4 APAC Acetaminophen-Opioid Combination Market Size Growth (2019-2024)
4.5 Europe Acetaminophen-Opioid Combination Market Size Growth (2019-2024)
4.6 Middle East & Africa Acetaminophen-Opioid Combination Market Size Growth (2019-2024)
5 Americas
5.1 Americas Acetaminophen-Opioid Combination Market Size by Country (2019-2024)
5.2 Americas Acetaminophen-Opioid Combination Market Size by Type (2019-2024)
5.3 Americas Acetaminophen-Opioid Combination Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acetaminophen-Opioid Combination Market Size by Region (2019-2024)
6.2 APAC Acetaminophen-Opioid Combination Market Size by Type (2019-2024)
6.3 APAC Acetaminophen-Opioid Combination Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Acetaminophen-Opioid Combination Market Size by Country (2019-2024)
7.2 Europe Acetaminophen-Opioid Combination Market Size by Type (2019-2024)
7.3 Europe Acetaminophen-Opioid Combination Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Acetaminophen-Opioid Combination by Region (2019-2024)
8.2 Middle East & Africa Acetaminophen-Opioid Combination Market Size by Type (2019-2024)
8.3 Middle East & Africa Acetaminophen-Opioid Combination Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Acetaminophen-Opioid Combination Market Forecast
10.1 Global Acetaminophen-Opioid Combination Forecast by Region (2025-2030)
10.1.1 Global Acetaminophen-Opioid Combination Forecast by Region (2025-2030)
10.1.2 Americas Acetaminophen-Opioid Combination Forecast
10.1.3 APAC Acetaminophen-Opioid Combination Forecast
10.1.4 Europe Acetaminophen-Opioid Combination Forecast
10.1.5 Middle East & Africa Acetaminophen-Opioid Combination Forecast
10.2 Americas Acetaminophen-Opioid Combination Forecast by Country (2025-2030)
10.2.1 United States Market Acetaminophen-Opioid Combination Forecast
10.2.2 Canada Market Acetaminophen-Opioid Combination Forecast
10.2.3 Mexico Market Acetaminophen-Opioid Combination Forecast
10.2.4 Brazil Market Acetaminophen-Opioid Combination Forecast
10.3 APAC Acetaminophen-Opioid Combination Forecast by Region (2025-2030)
10.3.1 China Acetaminophen-Opioid Combination Market Forecast
10.3.2 Japan Market Acetaminophen-Opioid Combination Forecast
10.3.3 Korea Market Acetaminophen-Opioid Combination Forecast
10.3.4 Southeast Asia Market Acetaminophen-Opioid Combination Forecast
10.3.5 India Market Acetaminophen-Opioid Combination Forecast
10.3.6 Australia Market Acetaminophen-Opioid Combination Forecast
10.4 Europe Acetaminophen-Opioid Combination Forecast by Country (2025-2030)
10.4.1 Germany Market Acetaminophen-Opioid Combination Forecast
10.4.2 France Market Acetaminophen-Opioid Combination Forecast
10.4.3 UK Market Acetaminophen-Opioid Combination Forecast
10.4.4 Italy Market Acetaminophen-Opioid Combination Forecast
10.4.5 Russia Market Acetaminophen-Opioid Combination Forecast
10.5 Middle East & Africa Acetaminophen-Opioid Combination Forecast by Region (2025-2030)
10.5.1 Egypt Market Acetaminophen-Opioid Combination Forecast
10.5.2 South Africa Market Acetaminophen-Opioid Combination Forecast
10.5.3 Israel Market Acetaminophen-Opioid Combination Forecast
10.5.4 Turkey Market Acetaminophen-Opioid Combination Forecast
10.6 Global Acetaminophen-Opioid Combination Forecast by Type (2025-2030)
10.7 Global Acetaminophen-Opioid Combination Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Acetaminophen-Opioid Combination Forecast
11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Acetaminophen-Opioid Combination Product Offered
11.1.3 Abbott Acetaminophen-Opioid Combination Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Endo Pharmaceuticals
11.2.1 Endo Pharmaceuticals Company Information
11.2.2 Endo Pharmaceuticals Acetaminophen-Opioid Combination Product Offered
11.2.3 Endo Pharmaceuticals Acetaminophen-Opioid Combination Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Endo Pharmaceuticals Main Business Overview
11.2.5 Endo Pharmaceuticals Latest Developments
11.3 骋谤眉苍别苍迟丑补濒
11.3.1 骋谤眉苍别苍迟丑补濒 Company Information
11.3.2 骋谤眉苍别苍迟丑补濒 Acetaminophen-Opioid Combination Product Offered
11.3.3 骋谤眉苍别苍迟丑补濒 Acetaminophen-Opioid Combination Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 骋谤眉苍别苍迟丑补濒 Main Business Overview
11.3.5 骋谤眉苍别苍迟丑补濒 Latest Developments
11.4 Hamilton Kent.
11.4.1 Hamilton Kent. Company Information
11.4.2 Hamilton Kent. Acetaminophen-Opioid Combination Product Offered
11.4.3 Hamilton Kent. Acetaminophen-Opioid Combination Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Hamilton Kent. Main Business Overview
11.4.5 Hamilton Kent. Latest Developments
11.5 Trio Remedies
11.5.1 Trio Remedies Company Information
11.5.2 Trio Remedies Acetaminophen-Opioid Combination Product Offered
11.5.3 Trio Remedies Acetaminophen-Opioid Combination Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Trio Remedies Main Business Overview
11.5.5 Trio Remedies Latest Developments
11.6 Purdue Pharmaceuticals
11.6.1 Purdue Pharmaceuticals Company Information
11.6.2 Purdue Pharmaceuticals Acetaminophen-Opioid Combination Product Offered
11.6.3 Purdue Pharmaceuticals Acetaminophen-Opioid Combination Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Purdue Pharmaceuticals Main Business Overview
11.6.5 Purdue Pharmaceuticals Latest Developments
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Information
11.7.2 Teva Pharmaceutical Acetaminophen-Opioid Combination Product Offered
11.7.3 Teva Pharmaceutical Acetaminophen-Opioid Combination Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Teva Pharmaceutical Main Business Overview
11.7.5 Teva Pharmaceutical Latest Developments
11.8 Laboratoire Riva
11.8.1 Laboratoire Riva Company Information
11.8.2 Laboratoire Riva Acetaminophen-Opioid Combination Product Offered
11.8.3 Laboratoire Riva Acetaminophen-Opioid Combination Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Laboratoire Riva Main Business Overview
11.8.5 Laboratoire Riva Latest Developments
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Information
11.9.2 Johnson & Johnson Acetaminophen-Opioid Combination Product Offered
11.9.3 Johnson & Johnson Acetaminophen-Opioid Combination Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Johnson & Johnson Main Business Overview
11.9.5 Johnson & Johnson Latest Developments
11.10 Mallinckrodt Pharmaceuticals
11.10.1 Mallinckrodt Pharmaceuticals Company Information
11.10.2 Mallinckrodt Pharmaceuticals Acetaminophen-Opioid Combination Product Offered
11.10.3 Mallinckrodt Pharmaceuticals Acetaminophen-Opioid Combination Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Mallinckrodt Pharmaceuticals Main Business Overview
11.10.5 Mallinckrodt Pharmaceuticals Latest Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Information
11.11.2 AstraZeneca Acetaminophen-Opioid Combination Product Offered
11.11.3 AstraZeneca Acetaminophen-Opioid Combination Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 AstraZeneca Main Business Overview
11.11.5 AstraZeneca Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂